Pembrolizumab’s Perioperative Power in Head and Neck Cancer

Adding pembrolizumab before and after surgery to standard of care improved outcomes in previously untreated head and neck cancer patients.

Read the full article here

Related Articles

Share Your Story

As a patient, survivor, or caregiver, your story can provide hope and inspiration to someone who’s been diagnosed with cancer or is undergoing therapy.